NEJM Group partner with Wolters Kluwer to expand global reach
Wolters Kluwer Health will serve as the exclusive digital distributor of subscriptions to the New England Journal of Medicine, NEJM Evidence, NEJM Catalyst and NEJM Journal Watch
Wolters Kluwer Health will serve as the exclusive digital distributor of subscriptions to the New England Journal of Medicine, NEJM Evidence, NEJM Catalyst and NEJM Journal Watch
Country-wide agreement results in 97% of eligible authors publishing open access articles
Clarivate annual G20 scorecard report reveals insights into world’s leading research economies
IOP Publishing is largest physics publisher to strike open access agreement with the Council of Australian University Librarians
Figshare integration is rolled out across further titles in the Nature portfolio, extending Springer Nature's commitment to open science
Submissions are open for Cochrane Evidence Synthesis and Methods
Institute for Scientific Information deepens qualitative analysis of annual list to improve detection of gaming, misconduct
Here are some key reasons you should not miss it
SAGE and the Italian consortium of Biomedical Research Libraries, Bibliosan, have announced a new open access agreement
The aim of the group and the blog is to provide unity by bringing together a range of different voices and perspectives that share the same commitment to open access
Interviews for this article have been adapted from recent PhaidraCon roundtable events and from upcoming 2023 editions of EpistemiCast
Patrick Hargitt explains why 2022 became the year that accessibility got serious
Joseph Koivisto and Jordan Sly from the University of Maryland discuss the implications of the publications-as-data model
Despite the collective and decisive step changes in enabling the transition to open access this year, we should not be complacent, writes Susie Winter
Thomas Shaw and Andrew Barker from Lancaster University Library discuss the realities, challenges and future impact of open access in the research community
It’s not a question of if, but how. The future of scholarly publishing is open, yet the debate on how to accelerate the growth of open access continues